The interdisciplinary research offers new look at complex braim tumors.
The interdisciplinary research offers new look at complex braim tumors.
Source: Rensselaer Polytechnic Institute

Imaging technique to study 3D printed brain tumors

Researchers demonstrated a methodology that combines the bioprinting and imaging of glioblastoma cells in a way that more closely models what happens inside the human body.

Glioblastomas are complex, fast-growing malignant brain tumors that are made up of various types of cells. Even with aggressive treatment — which often includes surgery, radiation, and chemotherapy — glioblastomas are difficult to treat, leading to an average survival of 11-15 months.

In research, Xavier Intes, a professor of biomedical engineering at Rensselaer, joined a multidisciplinary team from Northeastern University and the Icahn School of Medicine at Mount Sinai to demonstrate a methodology that combines the bioprinting and imaging of glioblastoma cells in a cost-effective way that more closely models what happens inside the human body. “There is a need to understand the biology and the complexity of the glioblastoma,” said Intes, who is also the co-director of the Center for Modeling, Simulation and Imaging for Medicine (CeMSIM) at Rensselaer. “What’s known is that glioblastomas are very complex in terms of their makeup, and this can differ from patient to patient.”

To create their 3D tumor cell model, a team, led by Guohao Dai, an associate professor of bioengineering at Northeastern University, made bioinks out of patient-derived tumor cells and printed them along with blood vessels. That vasculature allowed the printed tissue to live and mature, enabling researchers to study it over a matter of months.

The bioprinted blood vessels also provided channels for therapeutics to travel through — in this case, the chemotherapy drug Temozolomide. In the body, drug delivery to glioblastoma cells is especially complicated because of the blood-brain barrier, a wall of cells that blocks most substances from reaching the brain. Because it can more closely replicate this impediment, the team’s method provides a more accurate evaluation of a drug’s effectiveness than directly injecting the therapy into the cells. “That’s the unique part of the bioprinting that has been very powerful,” Intes said. “It’s closer to what would happen in vivo.”

In order to see if the therapeutic was making it to the glioblastoma cells and working, Intes and his team developed a specialized technique that could quickly take images of the bioprinted tissue at the cellular level through the thick Plexiglas container in which the tissue was contained — and could do so using as little light as possible, so as to not damage the cells. “We developed a new technology that allows us to go deeper than florescence microscopy,” Intes said. “It allows us to see, first, if the cells are growing, and then, if they respond to the drug.”

This technique, Intes said, could allow researchers to evaluate the effectiveness of multiple drugs at the same time. It is not yet realistic though, he points out, for studying the effectiveness of certain therapeutics on a person’s individual tumor because of the short time period in which clinicians often have to provide treatment.

Subscribe to our newsletter

Related articles

Active glioblastoma tumor 3D-bioprinted for the first time

Active glioblastoma tumor 3D-bioprinted for the first time

Researchers at Tel Aviv University have printed an entire active and viable glioblastoma tumor using a 3D printer.

3D printed tumor model shows interaction with immune cells

3D printed tumor model shows interaction with immune cells

Thanks to developments in 3D bioprinting, the UT researchers could create a miniature brain model representing the delicate tissue around the tumor, including the macrophages.

Deep learning: classifying brain tumors with a single 3D MRI scan

Deep learning: classifying brain tumors with a single 3D MRI scan

A team of researchers at Washington University School of Medicine have developed a deep learning model that is capable of classifying a brain tumor as one of six common types using a single 3D MRI scan.

Imaging technique to improve bioprinted implants

Imaging technique to improve bioprinted implants

Scientists have developed a new microscopic imaging approach to take a closer look at 3D printing for developing future patient implants, as well as improved disease modelling and drug screening.

First-ever living 3D-printed aneurysm

First-ever living 3D-printed aneurysm

Using 3D printing, researchers replicated an aneurysm in vitro and performed an endovascular repair procedure on the printed aneurysm.

Federated learning allows hospitals to share data privately

Federated learning allows hospitals to share data privately

Researchers have shown that federated learning is successful in the context of brain imaging, by being able to analyze MRI scans of brain tumor patients and distinguish healthy brain tissue from cancerous regions.

AI may help brain cancer patients avoid biopsy

AI may help brain cancer patients avoid biopsy

Brain cancer patients in the coming years may not need to go under the knife to help doctors determine the best treatment for their tumors.

AI & MRI look into the genome of brain tumors

AI & MRI look into the genome of brain tumors

Researcher have developed a computer method that uses MRI and machine learning to rapidly forecast genetic mutations in glioma tumors,

Creating a piece of mind

Creating a piece of mind

New 3D printing technique enables faster, better, and cheaper models of patient-specific medical data for research and diagnosis.

Popular articles

Subscribe to Newsletter